SOP Guide for Pharma

Manufacturing: SOP for Documentation of In-Process Observations – V 2.0

Manufacturing: SOP for Documentation of In-Process Observations – V 2.0

Standard Operating Procedure for Documentation of In-Process Observations


Department Manufacturing
SOP No. SOP/MFG/178/2025
Supersedes SOP/MFG/178/2022
Page No. Page 1 of 12
Issue Date 24/06/2025
Effective Date 25/06/2025
Review Date 24/06/2026

1. Purpose

This SOP outlines the process for documenting all in-process observations made during the manufacturing of sterile injectable products. Proper documentation ensures product traceability, deviation identification, and compliance with GMP and data integrity standards.

2. Scope

This SOP applies to all production areas involved in the sterile injectable manufacturing process including

solution preparation, filtration, filling, lyophilization, sealing, and packaging stages where critical observations are required.

3. Responsibilities

  • Production Operator: To make real-time entries of observed parameters and any events during processing.
  • Shift Supervisor: To verify entries and review for any anomalies or missing data.
  • Quality Assurance (QA): To audit and evaluate documentation accuracy and integrity.

4. Accountability

Head of Manufacturing shall be accountable for ensuring adherence to this SOP and timely review of all in-process observation records.

5. Procedure

5.1 Documentation Standards

  1. All entries must be made using a permanent blue or black ball pen.
  2. Entries must be made at the time of activity (contemporaneous).
  3. Do not leave blank spaces. Cross out unused lines with a single stroke and initial.
  4. Corrections must follow ALCOA+ principles:
    • Draw a single line through the incorrect entry.
    • Write the correct entry above or next to it.
    • Initial, date, and provide justification.
  5. Use standard templates as mentioned in Annexure-1 and Annexure-2.

5.2 Types of Observations to be Recorded

  1. Visual Observations:
    • Clarity of solution
    • Presence of particulate matter
    • Foaming, color changes, crystallization
  2. Process Observations:
    • Pressure differentials
    • Fill volume and weight variations
    • Sealing parameters (temperature, vacuum levels)
  3. Environmental Conditions:
    • Temperature and RH inside filling zone
    • Grade-A area monitoring status

5.3 Real-Time Recording

  1. Observations shall be noted in the In-Process Observation Log (Annexure-1) during each stage.
  2. Wherever automated data is collected (e.g., SCADA), manual confirmation or annotations shall be made.
  3. Entries must reflect:
    • Batch number
    • Stage of processing
    • Time of observation
    • Operator initials

5.4 Handling Abnormal Observations

  1. Any out-of-trend (OOT) or unusual observation must be immediately reported to the supervisor.
  2. Supervisor to evaluate and escalate to QA, if needed.
  3. Deviations must be documented in the Observation Deviation Form (Annexure-2).
  4. Follow SOP for deviation handling if required.

5.5 Review and Control

  1. All observation logs to be reviewed by QA within 24 hours of batch completion.
  2. QA shall ensure completeness, legibility, and data integrity.
  3. Logs to be archived in Batch Production Record (BPR) file.

5.6 Data Integrity Guidelines

  1. All data must be Attributable, Legible, Contemporaneous, Original, and Accurate (ALCOA).
  2. Avoid use of correction fluid or overwriting.
  3. Sign and date each entry with full name or employee code.

6. Abbreviations

  • SOP: Standard Operating Procedure
  • BPR: Batch Production Record
  • OOT: Out-of-Trend
  • QA: Quality Assurance
  • ALCOA: Attributable, Legible, Contemporaneous, Original, Accurate

7. Documents

  1. In-Process Observation Log – Annexure-1
  2. Observation Deviation Form – Annexure-2

8. References

  • WHO TRS 1019 Annex 4 – GMP for sterile products
  • MHRA GxP Data Integrity Guidance
  • ICH Q7 – Good Manufacturing Practice Guidance for Active Pharmaceutical Ingredients

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation Manufacturing Executive QA Executive Head QA
Department Production Quality Assurance Quality Assurance

11. Annexures

Annexure-1: In-Process Observation Log

Date Batch No. Stage Observation Time Initials
24/06/2025 BN-239A Filling No foam observed, clear solution 10:30 AM SK

Annexure-2: Observation Deviation Form

Date Batch No. Stage Description of Deviation Immediate Action QA Reviewed
23/06/2025 BN-238C Solution Prep Particulate matter observed in solution Solution filtered again Yes

Revision History:

Revision Date Revision No. Details Reason Approved By
01/02/2022 1.0 Initial Release New SOP QA Head
24/06/2025 2.0 Updated format and annexures Annual Review QA Head
Exit mobile version